Neurocrine Biosciences
NBIX
#1384
Rank
NZ$26.38 B
Marketcap
NZ$264.60
Share price
-1.21%
Change (1 day)
20.06%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend history for this company